Claritas Pharmaceuticals Inc V.CLAS.H

RE:RE:RE:RE:RE:RE:RE:RE:RE:BASHER ACCOUNTS : DEBBIECHANDLER , SCOTTY

[Sammythebull11]

MyKnight wrote: Here's a few reason:

1. World Monopoly for GVHD.
2. Market of 650 Millions/Year for Pre-GVHD(for the 6 big country only/min)
   1. This mean over a Billions a year for the full planet.
3. Market For Post(GVHD) not evaluated yet... would be Billions a year.
   1. People with GVHD symptom can leave over 20 years ...
4. Patent already setup for the planet.
5. Revenue out of Licences/Royalties, no big building to maintain and all cost that goes around this. Plain cash
6. Licence in Europe this Year, no need to wait for FDA Approval.
7. FDA Fast track and orphean drug for kaly.

Just to name a few...
That's for GVHD only.  They have a product call Kal-1816 that will compete on the opiod market(new ball game 50 Billions/year)... this will be on the few years to come. they also have other prodcut do your DD.

Now knowing that this business would bring you around a Billions a year, and would grab the full GVHD market.    If you we're  the CEO of a big pharma already dealing in the GVHD sector what would you do?

1. Let Kaly take the monopole and loose all revenu from GVHD
2. Licence at the beginning, once happy with the result buy them

I know what I would do, especially that 5 Billions for them is nothing for this market.

RE:RE:RE:RE:RE:RE:RE:BASHER ACCOUNTS : DEBBIECHANDLER , SCOTTY

Thanks for the respons MyKnight. I understand potential for sure, but why the figure of 2-5 b? I haven't run across anything myself to draw that conclusion. Can you share something I missed?
 

Thanks!